Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma
Open Access
- 1 March 2006
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 132 (6) , 743-746
- https://doi.org/10.1111/j.1365-2141.2005.05954.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- MCL-1 expression in B-cell non-Hodgkin’s lymphomasHuman Pathology, 2004
- Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavageOncogene, 2004
- Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?British Journal of Cancer, 2003
- Expression of apoptosis regulators in cutaneous T‐cell lymphoma (CTCL) cellsThe Journal of Pathology, 2003
- Expression of Mcl‐1 in mantle cell lymphoma is associated with high‐grade morphology, a high proliferative state, and p53 overexpressionThe Journal of Pathology, 2002
- Bcl‐2 family of proteins in indolent B‐cell non‐Hodgkin's lymphoma: Study of 116 casesAmerican Journal of Hematology, 2002
- Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's LymphomaBlood, 1997
- Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.Journal of Clinical Oncology, 1997
- Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)Nature, 1991
- Follicular center cell lymphoma. Morphologic data relating to observer reproducibilityCancer, 1986